Thyroid research published after controversial delay

Article Abstract:

The former Flint Laboratories, now a part of BASF AG's Knoll Pharmaceutical Co. subsidiary, delayed publication by more than six years of a study showing its Synthroid drug was no more effective than three other thyroid medications. Flint's contract with a researcher from the University of California at San Francisco forbade publication of the research results without Flint's written permission. The episode demonstrates the need for universities to establish procedures to prevent such prior restraint.

Scientific Research and Development Services, Research & Development-Universities, Thyroid & Antithyroid Prep, Publishing industry, Pharmaceutical industry, Drug therapy, Medical research, Public relations, Thyroid diseases, University of California (San Francisco), University research, Knoll Pharmaceutical Co., Synthroid (Medication)

---

Thrombolytic therapy underused in elderly patients

Article Abstract:

Thrombolytic therapy is not used by many elderly patients who suffer from acute myocardial infarction although they are eligible for it, according to Harlan M. Krumholz, MD, in the Journal of the American Medical Assn. An 18% reduction in the chances of dying has been shown in past clinical trials involving almost 60,000 patients. Advanced age (20%) and delay in seeking treatment (36%) were the most common reasons for not using the therapy.

Care and treatment, Usage, Heart attack, Thrombolytic therapy

---

Hormone therapy boosts postmenopausal life expectancy

Article Abstract:

A study published in the Apr 9, 1997, edition of the Journal of the American Medical Association indicates that hormone replacement therapy boosts life expectancy for all women with even a single coronary heart disease (CHD) risk factor. The study by Dr. Nanada F. Col and colleagues indicated that only women at the highest risk of breast cancer and the lowest risk of CHD would not benefit from the therapy.

Menopausal Treatment Hormones, Health aspects, Women, Hormone therapy, Hormones, Women's health, Postmenopausal women, Menopause treatment agents

Similar abstracts:

• Abstracts: Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction
• Abstracts: The role of early HIV infection in the spread of HIV through populations. Mutation takes no vacation: can structured treatment interruptions increase the risk of drug-resistant HIV-1?
• Abstracts: The wonder of ICU. Child health in the community. Healthy questions
• Abstracts: Kaiser feels market crunch, HMO sees its first-ever loss. Taking pulse of profession, public: managed care, end-of-life treatment among topics in AMA poll
• Abstracts: AMA treads middle ground on residents' unions. Competition turns friends into foes

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.